Saá Paula, Castilla Joaquín, Soto Claudio
Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA.
Methods Mol Biol. 2005;299:53-65. doi: 10.1385/1-59259-874-9:053.
Diverse human disorders, including most neurodegenerative diseases, are thought to arise from the misfolding and aggregation of an underlying protein. We have recently described a novel technology to amplify cyclically the misfolding and aggregation process in vitro. This procedure, named protein misfolding cyclic amplification (PMCA), conceptually analogous to DNA amplification by PCR, has tremendous implications for research and diagnosis. The PMCA concept has been proved on the amplification of prions implicated in the pathogenesis of transmissible spongiform encephalopathies (TSE). In these diseases, there is a tremendous need for early and sensitive biochemical diagnosis to minimize the further spreading of the prion infectious agent through the food chain. In this chapter, we describe the principles behind the PMCA technology, its application, and methodology to detect minute quantities of misfolded prion protein and its potential to be used for amplification of misfolding of other proteins implicated in diverse diseases.
包括大多数神经退行性疾病在内的多种人类疾病,被认为是由一种潜在蛋白质的错误折叠和聚集所引发的。我们最近描述了一种在体外循环放大错误折叠和聚集过程的新技术。这个过程被称为蛋白质错误折叠循环扩增(PMCA),在概念上类似于通过PCR进行的DNA扩增,对研究和诊断具有重大意义。PMCA概念已在与传染性海绵状脑病(TSE)发病机制相关的朊病毒扩增方面得到证实。在这些疾病中,迫切需要早期且灵敏的生化诊断,以尽量减少朊病毒感染因子通过食物链的进一步传播。在本章中,我们描述了PMCA技术背后的原理、其应用以及检测微量错误折叠朊病毒蛋白的方法,以及其用于扩增与多种疾病相关的其他蛋白质错误折叠的潜力。